Literature DB >> 19551832

Seroprevalence of Kaposi's sarcoma-associated herpesvirus and risk factors in Xinjiang, China.

Bishi Fu1, Feng Sun, Baolin Li, Lei Yang, Yan Zeng, Xiulian Sun, Fanhong Xu, Simon Rayner, Moraima Guadalupe, Shou-Jiang Gao, Linding Wang.   

Abstract

Xinjiang, China is an endemic area for Kaposi's sarcoma (KS) but the seroprevalence of Kaposi's sarcoma-associated herpesvirus (KSHV) and risk factors remain undefined. In this study, antibodies to one KSHV latent protein (ORF73) and two KSHV lytic proteins (ORF65 and ORF-K8.1) were examined in 2,228 subjects from the general population and 37 subjects infected with HIV-1 in Xinjiang, and 560 subjects from the general population in Hubei, a low KS incidence region. The serostatus of a serum sample was defined based on positive results in any one of the three serologic assays. The seroprevalence of KSHV in the general population was higher in Xinjiang than in Hubei (19.2% vs. 9.5%; odds ratios [OR], 2.28; 95% confidence interval [CI], 1.68-3.08; P < 0.001). Among the ethnic groups in Xinjiang, 68 (15.8%) Han, 182 (20.7%) Uygur, 140 (19.9%) Hazakh, 9 (33.3%) Xibo, and 29 (16.8%) Hui were KSHV-seropositive, respectively. Compared to the Han, the latter groups had an increase in the risk of KSHV of 62.2%, 63.8%, 180.1%, and 30.2% (P = 0.003, 0.004, 0.018, and 0.286, respectively). Subjects aged <20, 20-50, and >50 had a seroprevalence of KSHV of 11.8%, 17.9%, and 24.6%, respectively. Compared to subjects aged <20, the latter groups had an increase in the risk of KSHV of 63.3% and 144.5% (P = 0.009 and <0.001, respectively). Subjects infected with HIV-1 in Xinjiang had a seroprevalence of KSHV of 43.2%, and a 220% increase in the risk of KSHV compared to the general population (P < 0.001). Similar results were obtained when the seroprevalence of KSHV was analyzed with any single or two of the three serologic assays alone. Genotyping identified three unique sequences clustered in the A clade. This study indicates that Xinjiang has a high seroprevalence of KSHV. Geographic location, ethnicity, age and HIV-1 infection are risk factors. Serologic and genotyping results suggest the introduction of KSHV into Xinjiang by specific ethnic groups.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19551832      PMCID: PMC2755560          DOI: 10.1002/jmv.21550

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  35 in total

1.  Antibodies against human herpesvirus 8 in black South African patients with cancer.

Authors:  F Sitas; H Carrara; V Beral; R Newton; G Reeves; D Bull; U Jentsch; R Pacella-Norman; D Bourboulia; D Whitby; C Boshoff; R Weiss
Journal:  N Engl J Med       Date:  1999-06-17       Impact factor: 91.245

2.  Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients.

Authors:  C Parravicini; S J Olsen; M Capra; F Poli; G Sirchia; S J Gao; E Berti; A Nocera; E Rossi; G Bestetti; M Pizzuto; M Galli; M Moroni; P S Moore; M Corbellino
Journal:  Blood       Date:  1997-10-01       Impact factor: 22.113

3.  Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma.

Authors:  S J Gao; L Kingsley; D R Hoover; T J Spira; C R Rinaldo; A Saah; J Phair; R Detels; P Parry; Y Chang; P S Moore
Journal:  N Engl J Med       Date:  1996-07-25       Impact factor: 91.245

4.  Seroprevalence of human herpesvirus 8 in human immunodeficiency virus 1-positive and human immunodeficiency virus 1-negative populations in Japan.

Authors:  T Fujii; H Taguchi; H Katano; S Mori; T Nakamura; N Nojiri; K Nakajima; K Tadokoro; T Juji; A Iwamoto
Journal:  J Med Virol       Date:  1999-02       Impact factor: 2.327

5.  High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia.

Authors:  A Angeloni; L Heston; S Uccini; M C Sirianni; F Cottoni; M V Masala; D Cerimele; S F Lin; R Sun; M Rigsby; A Faggioni; G Miller
Journal:  J Infect Dis       Date:  1998-06       Impact factor: 5.226

6.  Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.

Authors:  G R Simpson; T F Schulz; D Whitby; P M Cook; C Boshoff; L Rainbow; M R Howard; S J Gao; R A Bohenzky; P Simmonds; C Lee; A de Ruiter; A Hatzakis; R S Tedder; I V Weller; R A Weiss; P S Moore
Journal:  Lancet       Date:  1996-10-26       Impact factor: 79.321

7.  Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.

Authors:  L Zhu; R Wang; A Sweat; E Goldstein; R Horvat; B Chandran
Journal:  Virology       Date:  1999-04-10       Impact factor: 3.616

8.  KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma.

Authors:  S J Gao; L Kingsley; M Li; W Zheng; C Parravicini; J Ziegler; R Newton; C R Rinaldo; A Saah; J Phair; R Detels; Y Chang; P S Moore
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

9.  The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women.

Authors:  D H Kedes; D Ganem; N Ameli; P Bacchetti; R Greenblatt
Journal:  JAMA       Date:  1997-02-12       Impact factor: 56.272

10.  Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection.

Authors:  G Miller; M O Rigsby; L Heston; E Grogan; R Sun; C Metroka; J A Levy; S J Gao; Y Chang; P Moore
Journal:  N Engl J Med       Date:  1996-05-16       Impact factor: 91.245

View more
  25 in total

1.  Human herpesvirus-8 in northwestern China: epidemiology and characterization among blood donors.

Authors:  Xing Wang; Bin He; Zhaoxia Zhang; Tao Liu; Hui Wang; Xu Li; Qiong Zhang; Ke Lan; Xiaomei Lu; Hao Wen
Journal:  Virol J       Date:  2010-03-17       Impact factor: 4.099

2.  High prevalence of early childhood infection by Kaposi's sarcoma-associated herpesvirus in a minority population in China.

Authors:  Y Cao; V Minhas; X Tan; J Huang; B Wang; M Zhu; Y Gao; T Zhao; L Yang; C Wood
Journal:  Clin Microbiol Infect       Date:  2013-08-28       Impact factor: 8.067

3.  Gender differences in Kaposi's sarcoma-associated herpesvirus infection in a population with schistosomiasis in rural China.

Authors:  Bishi Fu; Rongge Yang; Fan Xia; Baolin Li; Xinxing Ouyang; Shou-Jiang Gao; Linding Wang
Journal:  Jpn J Infect Dis       Date:  2012-07       Impact factor: 1.362

4.  Prevalence of human herpesvirus 8 and hepatitis C virus in a rural community with a high risk for blood-borne infections in central China.

Authors:  T Zhang; N He; Y Ding; K Crabtree; V Minhas; C Wood
Journal:  Clin Microbiol Infect       Date:  2011-03       Impact factor: 8.067

5.  Antibody responses to lytic and latent human herpesvirus 8 antigens among HIV-infected patients in central China.

Authors:  T J Zhang; N He; Y Y Ding; Q W Jiang; C Wood
Journal:  Biosci Trends       Date:  2012-06       Impact factor: 2.400

6.  Virological and molecular characterization of Kaposi's sarcoma-associated herpesvirus strains from Xinjiang, China.

Authors:  X Wang; H Wang; B He; Y Hui; G Lv; L Li; H Wen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-03       Impact factor: 3.267

7.  Seroprevalence and determinants of Kaposi sarcoma-associated human herpesvirus 8 in Indian HIV-infected males.

Authors:  Arshi Munawwar; Surendra K Sharma; Somesh Gupta; Sarman Singh
Journal:  AIDS Res Hum Retroviruses       Date:  2014-12       Impact factor: 2.205

Review 8.  Is human herpesvirus 8 infection more common in men than in women? Systematic review and meta-analysis.

Authors:  Lorin Begré; Eliane Rohner; Sam M Mbulaiteye; Matthias Egger; Julia Bohlius
Journal:  Int J Cancer       Date:  2016-04-26       Impact factor: 7.396

Review 9.  Kaposi sarcoma associated herpesvirus pathogenesis (KSHV)--an update.

Authors:  Dirk P Dittmer; Blossom Damania
Journal:  Curr Opin Virol       Date:  2013-06-13       Impact factor: 7.090

10.  Human oncogenic viruses: nature and discovery.

Authors:  Yuan Chang; Patrick S Moore; Robin A Weiss
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-19       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.